Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna S Berghoff

Showing results (1-10 of 165) with videos related to

Pageof 17
Sort By:
Chinese Clinical Oncology|June 27, 2015
The inflammatory microenvironment in brain metastases: potential treatment target?Anna S Berghoff, Matthias Preusser
Memo|April 3, 2018
Anti-angiogenic therapies in brain metastasesAnna S Berghoff, Matthias Preusser
Expert Review of Anticancer Therapy|November 16, 2020
Brain metastases in metastatic cancer: a review of recent advances in systemic therapiesAriane Steindl, Anna S Berghoff
Nature Reviews. Neurology|April 3, 2019
Does neoadjuvant anti-PD1 therapy improve glioblastoma outcome?Anna S Berghoff, Matthias Preusser
Therapeutic Advances in Neurological Disorders|July 24, 2018
New developments in brain metastasesAnna S Berghoff, Matthias Preusser
Current Treatment Options in Neurology|April 5, 2017
Targeted Therapies for Melanoma Brain MetastasesAnna S Berghoff, Matthias Preusser
Clinical Neuropathology|October 23, 2012
Clinical neuropathology practice guide 06-2012: MGMT testing in elderly glioblastoma patients--yes, but how?Anna S Berghoff, Matthias Preusser
Expert Review of Anticancer Therapy|October 31, 2013
Biology in prevention and treatment of brain metastasesAnna S Berghoff, Matthias Preusser
Future Oncology (London, England)|August 12, 2015
The future of targeted therapies for brain metastasesAnna S Berghoff, Matthias Preusser
Clinical Neuropathology|February 9, 2021
Reply to comment on "Analysis of the inflammatory tumor microenvironment in meningeal neoplasms"Anna S Berghoff, Matthias Preusser
Pageof 17

Showing results (1-10 of 165) with videos related to

Sort By:
Pageof 17
Chinese Clinical Oncology|June 27, 2015
The inflammatory microenvironment in brain metastases: potential treatment target?Anna S Berghoff, Matthias Preusser
Memo|April 3, 2018
Anti-angiogenic therapies in brain metastasesAnna S Berghoff, Matthias Preusser
Expert Review of Anticancer Therapy|November 16, 2020
Brain metastases in metastatic cancer: a review of recent advances in systemic therapiesAriane Steindl, Anna S Berghoff
Nature Reviews. Neurology|April 3, 2019
Does neoadjuvant anti-PD1 therapy improve glioblastoma outcome?Anna S Berghoff, Matthias Preusser
Therapeutic Advances in Neurological Disorders|July 24, 2018
New developments in brain metastasesAnna S Berghoff, Matthias Preusser
Current Treatment Options in Neurology|April 5, 2017
Targeted Therapies for Melanoma Brain MetastasesAnna S Berghoff, Matthias Preusser
Clinical Neuropathology|October 23, 2012
Clinical neuropathology practice guide 06-2012: MGMT testing in elderly glioblastoma patients--yes, but how?Anna S Berghoff, Matthias Preusser
Expert Review of Anticancer Therapy|October 31, 2013
Biology in prevention and treatment of brain metastasesAnna S Berghoff, Matthias Preusser
Future Oncology (London, England)|August 12, 2015
The future of targeted therapies for brain metastasesAnna S Berghoff, Matthias Preusser
Clinical Neuropathology|February 9, 2021
Reply to comment on "Analysis of the inflammatory tumor microenvironment in meningeal neoplasms"Anna S Berghoff, Matthias Preusser
Pageof 17